Table of Contents

2019-2024 Global Corticosteroid Injections for Joint Pain Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Corticosteroid Injections for Joint Pain Consumption 2014-2024
2.1.2 Corticosteroid Injections for Joint Pain Consumption CAGR by Region
2.2 Corticosteroid Injections for Joint Pain Segment by Type
2.2.1 Knee & Ankle
2.2.2 Hip Joint
2.2.3 Shoulder & Elbow
2.2.4 Facet Joints of the Spine
2.2.5 Others
2.3 Corticosteroid Injections for Joint Pain Consumption by Type
2.3.1 Global Corticosteroid Injections for Joint Pain Consumption Market Share by Type (2014-2019)
2.3.2 Global Corticosteroid Injections for Joint Pain Revenue and Market Share by Type (2014-2019)
2.3.3 Global Corticosteroid Injections for Joint Pain Sale Price by Type (2014-2019)
2.4 Corticosteroid Injections for Joint Pain Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Corticosteroid Injections for Joint Pain Consumption by Application
2.5.1 Global Corticosteroid Injections for Joint Pain Consumption Market Share by Application (2014-2019)
2.5.2 Global Corticosteroid Injections for Joint Pain Value and Market Share by Application (2014-2019)
2.5.3 Global Corticosteroid Injections for Joint Pain Sale Price by Application (2014-2019)

3 Global Corticosteroid Injections for Joint Pain by Players
3.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Players
3.1.1 Global Corticosteroid Injections for Joint Pain Sales by Players (2017-2019)
3.1.2 Global Corticosteroid Injections for Joint Pain Sales Market Share by Players (2017-2019)
3.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Players
3.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Players (2017-2019)
3.2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Players (2017-2019)
3.3 Global Corticosteroid Injections for Joint Pain Sale Price by Players
3.4 Global Corticosteroid Injections for Joint Pain Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Corticosteroid Injections for Joint Pain Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Corticosteroid Injections for Joint Pain Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Corticosteroid Injections for Joint Pain by Regions
4.1 Corticosteroid Injections for Joint Pain by Regions
4.1.1 Global Corticosteroid Injections for Joint Pain Consumption by Regions
4.1.2 Global Corticosteroid Injections for Joint Pain Value by Regions
4.2 Americas Corticosteroid Injections for Joint Pain Consumption Growth
4.3 APAC Corticosteroid Injections for Joint Pain Consumption Growth
4.4 Europe Corticosteroid Injections for Joint Pain Consumption Growth
4.5 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption Growth

5 Americas
5.1 Americas Corticosteroid Injections for Joint Pain Consumption by Countries
5.1.1 Americas Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
5.1.2 Americas Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
5.2 Americas Corticosteroid Injections for Joint Pain Consumption by Type
5.3 Americas Corticosteroid Injections for Joint Pain Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Corticosteroid Injections for Joint Pain Consumption by Countries
6.1.1 APAC Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
6.1.2 APAC Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
6.2 APAC Corticosteroid Injections for Joint Pain Consumption by Type
6.3 APAC Corticosteroid Injections for Joint Pain Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Corticosteroid Injections for Joint Pain by Countries
7.1.1 Europe Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
7.1.2 Europe Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
7.2 Europe Corticosteroid Injections for Joint Pain Consumption by Type
7.3 Europe Corticosteroid Injections for Joint Pain Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Corticosteroid Injections for Joint Pain by Countries
8.1.1 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
8.2 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption by Type
8.3 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Corticosteroid Injections for Joint Pain Distributors
10.3 Corticosteroid Injections for Joint Pain Customer

11 Global Corticosteroid Injections for Joint Pain Market Forecast
11.1 Global Corticosteroid Injections for Joint Pain Consumption Forecast (2019-2024)
11.2 Global Corticosteroid Injections for Joint Pain Forecast by Regions
11.2.1 Global Corticosteroid Injections for Joint Pain Forecast by Regions (2019-2024)
11.2.2 Global Corticosteroid Injections for Joint Pain Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Corticosteroid Injections for Joint Pain Forecast by Type
11.8 Global Corticosteroid Injections for Joint Pain Forecast by Application

12 Key Players Analysis
12.1 Allergan
12.1.1 Company Details
12.1.2 Corticosteroid Injections for Joint Pain Product Offered
12.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Pfizer
12.2.1 Company Details
12.2.2 Corticosteroid Injections for Joint Pain Product Offered
12.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Pfizer News
12.3 Sanofi
12.3.1 Company Details
12.3.2 Corticosteroid Injections for Joint Pain Product Offered
12.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Sanofi News
12.4 Anika Therapeutics
12.4.1 Company Details
12.4.2 Corticosteroid Injections for Joint Pain Product Offered
12.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Anika Therapeutics News
12.5 Ferring
12.5.1 Company Details
12.5.2 Corticosteroid Injections for Joint Pain Product Offered
12.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Ferring News
12.6 Bioventus
12.6.1 Company Details
12.6.2 Corticosteroid Injections for Joint Pain Product Offered
12.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Bioventus News
12.7 Flexion Therapeutics
12.7.1 Company Details
12.7.2 Corticosteroid Injections for Joint Pain Product Offered
12.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Flexion Therapeutics News
12.8 Zimmer Biomet
12.8.1 Company Details
12.8.2 Corticosteroid Injections for Joint Pain Product Offered
12.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Zimmer Biomet News
12.9 SEIKAGAKU
12.9.1 Company Details
12.9.2 Corticosteroid Injections for Joint Pain Product Offered
12.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 SEIKAGAKU News
12.10 Chugai Pharma
12.10.1 Company Details
12.10.2 Corticosteroid Injections for Joint Pain Product Offered
12.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Chugai Pharma News

13 Research Findings and Conclusion